⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TARS News
Tarsus Pharmaceuticals, Inc. Common Stock
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
globenewswire.com
TARS
Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer
globenewswire.com
TARS
Form 8-K
sec.gov
LSTA
TARS
ACHV
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
globenewswire.com
TARS
LSTA
ACHV
Form 8-K/A
sec.gov
TARS
MassChallenge Establishes MC Innovation Fund with $2 Million Founding Gift from Amy and Joshua Boger
prnewswire.com
TARS
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
globenewswire.com
TARS
Form 8-K
sec.gov
TARS
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
globenewswire.com
TARS
Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease
globenewswire.com
TARS